Future Oncology, Volume 16, Issue 34 (2020)

Browse this journal
Sample our Health and Social Care journals, sign in here to start your FREE access for 14 days

Future Oncology, Volume 16, Issue 34 (2020)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Vol 18, 2022 Vol 17, 2021 Volume 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

Editorial

Editorial
Bioethical Considerations for Cancer Patient Care During the COVID-19 Pandemic
Hampig Raphael Kourie, Roland Eid, Fady Gh Haddad, Michel Scheuer & Roland Tomb
Pages: 2779-2781
Published online: 09 Sep 2020
First Page PreviewforBioethical Considerations for Cancer Patient Care During the COVID-19 Pandemic | Full Text | References | PDF (1.3 MB) | EPUB
  • 1572 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Drug Evaluation

Review Article
Belantamab Mafodotin in the Treatment of Relapsed or Refractory Multiple Myeloma
Semira Sheikh, Eyal Lebel & Suzanne Trudel
Pages: 2783-2798
Published online: 02 Sep 2020
AbstractforBelantamab Mafodotin in the Treatment of Relapsed or Refractory Multiple Myeloma | Full Text | References | PDF (1.6 MB) | EPUB
  • 464 Views
  • 11 CrossRef citations
  • 0Altmetric

Short Communication

Brief Report
Sequential Afatinib and Osimertinib in Patients with EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Final Analysis of the GioTag Study
Maximilian J Hochmair, Alessandro Morabito, Desiree Hao, Cheng-Ta Yang, Ross A Soo, James C-H Yang, Rasim Gucalp, Balazs Halmos, Angela Märten & Tanja Cufer
Pages: 2799-2808
Published online: 28 Aug 2020
AbstractforSequential Afatinib and Osimertinib in Patients with EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Final Analysis of the GioTag Study | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
Infographic: A PDF version of this infographic is available as supplemental material.
  • 32456 Views
  • 42 CrossRef citations
  • 0Altmetric
Open Access

Research Article

Article
Syt-7 Overexpression Predicts Poor Prognosis and Promotes Cell Proliferation in Hepatocellular Carcinoma
Hao Jin, Qing Pang, Meifang Fang, Yong Wang, Zhongran Man, Yi Tan & Huichun Liu
Pages: 2809-2819
Published online: 14 Oct 2020
AbstractforSyt-7 Overexpression Predicts Poor Prognosis and Promotes Cell Proliferation in Hepatocellular Carcinoma | Full Text | References | PDF (8.1 MB) | EPUB
  • 116 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Identification of Key Factors Associated with Early- and Late-Onset Ovarian Serous Cystadenocarcinoma
Shuang Ma, Yang Zheng & Chengwei Fei
Pages: 2821-2833
Published online: 04 Sep 2020
AbstractforIdentification of Key Factors Associated with Early- and Late-Onset Ovarian Serous Cystadenocarcinoma | Full Text | References | PDF (2.1 MB) | EPUB | Supplemental
  • 110 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Survival Nomogram for Patients with Upper Tract Recurrence After Resection for Localized Bladder Urothelial Carcinoma
Guangdong Hou, Wanxiang Zheng, Wei Zhang, Yu Zheng, Lei Zhang, Ming Gao, Fei Yan, Di Wei, Fuli Wang & Jianlin Yuan
Pages: 2835-2844
Published online: 05 Sep 2020
AbstractforSurvival Nomogram for Patients with Upper Tract Recurrence After Resection for Localized Bladder Urothelial Carcinoma | Full Text | References | PDF (1.4 MB) | EPUB
  • 76 Views
  • 1 CrossRef citations
  • 0Altmetric

Special Report

Review Article
Artificial Intelligence Technology Applications in the Pathologic Diagnosis of the Gastrointestinal Tract
Leonardo S Lino-Silva & Diana L Xinaxtle
Pages: 2845-2851
Published online: 05 Sep 2020
AbstractforArtificial Intelligence Technology Applications in the Pathologic Diagnosis of the Gastrointestinal Tract | Full Text | References | PDF (3.4 MB) | EPUB
  • 242 Views
  • 2 CrossRef citations
  • 0Altmetric

Review

Review Article
CD38 as an Immunomodulator in Cancer
Yanli Li, Rui Yang, Limo Chen & Sufang Wu
Pages: 2853-2861
Published online: 28 Aug 2020
AbstractforCD38 as an Immunomodulator in Cancer | Full Text | References | PDF (1.3 MB) | EPUB
  • 749 Views
  • 12 CrossRef citations
  • 0Altmetric
Review Article
Clinical Applications of Circulating Tumor DNA in Monitoring Breast Cancer Drug Resistance
Yang Liu, Qian Du, Dan Sun, Ruiying Han, Mengmeng Teng, Siying Chen, Haisheng You & Yalin Dong
Pages: 2863-2878
Published online: 25 Sep 2020
AbstractforClinical Applications of Circulating Tumor DNA in Monitoring Breast Cancer Drug Resistance | Full Text | References | PDF (3.8 MB) | EPUB
  • 301 Views
  • 2 CrossRef citations
  • 0Altmetric

Systematic Review

Review Article
The Clinical Significance of Routine Risk Categorization in Metastatic Renal Cell Carcinoma and its Impact on Treatment Decision-Making: A Systematic Review
Shouki Bazarbashi, Abdullah Alsharm, Faisal Azam, Hazem El Ashry & Jamal Zekri
Pages: 2879-2896
Published online: 01 Sep 2020
AbstractforThe Clinical Significance of Routine Risk Categorization in Metastatic Renal Cell Carcinoma and its Impact on Treatment Decision-Making: A Systematic Review | Full Text | References | PDF (1.5 MB) | EPUB
  • 2163 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Corrigendum

Correction
Corrigendum
Page: 2897
Published online: 08 Dec 2020
CitationforCorrigendum | Full Text | PDF (1.2 MB) | EPUB
  • 128 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Real-world first-line treatment patterns and outcomes in recurrent/advanced endometrial cancer patients in Europe
Jingchuan Zhang et al.
Rapid Communication | Published online: 9 Aug 2024
Open Access
Abemaciclib for treating patients with HR+/HER2- metastatic breast cancer: a real-world study in France, Italy and Spain
Isabel Blancas et al.
Rapid Communication | Published online: 8 Aug 2024
Open Access
A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer
James J Harding et al.
Plain Language Summary of Publication | Published online: 8 Aug 2024
Open Access
Plain language summary of the CARTITUDE-4 study of ciltacabtagene autoleucel for the treatment of people with relapsed or refractory multiple myeloma
Jesús San-Miguel et al.
Plain Language Summary of Publication | Published online: 7 Aug 2024
Open Access
View all latest articles